Last edition
News about "Vyome Holdings"
Vyome Secures China Patent for Besifloxacin Topical Gel in Inflammatory Acne Treatment
Vyome Holdings has secured a Chinese patent for its proprietary besifloxacin topical gel programme, strengthening intellectual property protection for inflammatory acne treatment and expanding future commercial opportunities in one of the world's largest dermatology markets.
Vyome Holdings | 04/07/2026 | By News Bureau
Vyome and Embryyo Sign MoU to Advance AI-Enabled Medical Devices
US-based Vyome Holdings has signed an MoU with Embryyo Technologies, India’s leading medical device innovation studio, to jointly explore opportunities in the multi-billion-dollar AI-enabled medical device market.
Vyome Holdings | 22/08/2025 | By Dineshwori | 171
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy